Analysis of frailty status and associated factors in elderly patients with benign prostatic hyperplasia
Abstract
Background: To explore the current status of frailty in elderly patients with benign prostatic hyperplasia (BPH) and analyze the influencing factors. Methods: This study used a cross-sectional design, in which we selected 220 inpatients aged >60 years who were admitted to the Departments of Geriatrics and Urology and diagnosed with BPH. Participants were categorized into a non-frail (normal) group (n = 83) and a frail group (n = 137) according to the Tilburg Frailty Indicator (TFI). General characteristics were collected, and the Mini Nutritional Assessment-Short Form (MNA-SF), Montreal Cognitive Assessment (MoCA), and a reverse questionnaire survey were administered. Univariate analysis, correlation analysis, and binary logistic regression were conducted to identify factors associated with frailty in elderly BPH patients. Results: Univariate analysis showed that the main factors influencing frailty in elderly BPH patients were age, International Prostate Symptom Score (IPSS), disease duration, alcohol consumption, body mass index (BMI), personal monthly income, number of chronic diseases, MNA-SF score, and MoCA score (all p < 0.05). The total TFI score was negatively correlated with both MNA-SF (r = −0.297) and MoCA (r = −0.209), and these correlations were statistically significant (p < 0.05). In the binary logistic regression analysis, IPSS score, disease duration, alcohol consumption, number of chronic diseases, and MNA-SF score emerged as the main factors associated…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 137 participants or records.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.